Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
The use of data generated passively by personal electronic devices, such as smartphones, to measure human function in health and disease has generated significant research interest. Particularly in psychiatry, objective, continuous quantitation using patients’ own devices may result in clinically useful markers that can be used to refine diagnostic processes, tailor treatment choices, improve condition monitoring for actionable outcomes, such as early signs of relapse, and develop new intervention models. If a principal goal for digital phenotyping is clinical improvement, research needs to attend now to factors that will help or hinder future clinical adoption. We identify four opportunities for research directed toward this goal: exploring intermediate outcomes and underlying disease mechanisms; focusing on purposes that are likely to be used in clinical practice; anticipating quality and safety barriers to adoption; and exploring the potential for digital personalized medicine arising from the integration of digital phenotyping and digital interventions. Clinical relevance also means explicitly addressing consumer needs, preferences, and acceptability as the ultimate users of digital phenotyping interventions. There is a risk that, without such considerations, the potential benefits of digital phenotyping are delayed or not realized because approaches that are feasible for application in healthcare, and the evidence required to support clinical commissioning, are not developed. Practical steps to accelerate this research agenda include the further development of digital phenotyping technology platforms focusing on scalability and equity, establishing shared data repositories and common data standards, and fostering multidisciplinary collaborations between clinical stakeholders (including patients), computer scientists, and researchers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both traditional ML approaches (e.g., support vector machines, logistic regression, XGBoost) and deep learning methods (e.g., convolutional and recurrent neural networks, transformers) have shown success in distinguishing individuals with AD, MCI, FTD, including PPA, or PD from healthy controls.93–96”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [96]
Experimental — accuracy not yet measuredIn the citing paper
“Digital phenotyping is in its infancy; more research is needed to support scalable passive sensor data collection, processing and analyses and to integrate this approach into the clinical assessment and treatment of neurobehavioural disorders. 101”
From Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders (2021) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Taking the Human Out of the Loop: A Review of Bayesian Optimization
Shahriari, B., Swersky, K., Wang, Z., Adams, R. P., & de Freitas, N. (2016) · Proceedings of the IEEE · doi:10.1109/jproc.2015.2494218 · Cited by 6,049
The answer is 17 years, what is the question: understanding time lags in translational research
Morris, Z. S., Wooding, S., & Grant, J. (2011) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2011.110180 · Cited by 3,340
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Cognitive impairment in depression: a systematic review and meta-analysis
Rock, P. L., Roiser, J. P., Riedel, W. J., & Blackwell, A. D. (2014) · Psychological Medicine · doi:10.1017/s0033291713002535 · Cited by 2,161
Ensuring fairness in machine learning to advance health equity.
Rajkomar, A., Hardt, M., Howell, M. D., Corrado, G., & Chin, M. H. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1990 · Cited by 1,341
Vickers, A. J., Van Calster, B., & Steyerberg, E. W. (2016) · BMJ · doi:10.1136/bmj.i6 · Cited by 1,163
What makes UK Biobank special?
Collins, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60404-8 · Cited by 1,128
How Can We Increase Translation of Research into Practice? Types of Evidence Needed
Glasgow, R. E., & Emmons, K. M. (2007) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.28.021406.144145 · Cited by 1,050
A meta-analysis of depression severity and cognitive function
McDermott, L. M., & Ebmeier, K. P. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.022 · Cited by 956
Research works printed but not linked: 5
- Rush, A. J. et al. STAR*D: revising conventional wisdom. CNS drugs 23, 627–647 (2009).
- Byrnes, H. F. et al. Presence and characteristics of alcohol outlets perceived during daily travels: relationswith teen alcohol use, attitudes, and access. Alcohol.: Clin. Exp. Res. 42, 54A (2018).
- Boyle, S. C. The social mindfeed project: using objective assessment methods to better understand the nature of social-media based peer alcohol influence. Alcohol.: Clin. Exp. Res. 42, 280A (2018).
- Frank, E. et al. Sensing depression: Using smartphone sensors to predict changes in depression severity. Neuropsychopharmacology 43, S346 (2017).
- Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. National Academy Press, Washington, DC, USA, 2001).
Cited by
Holmes, E. A., O'Connor, R. C., Perry, V. H., Tracey, I., Wessely, S., Arseneault, L., Ballard, C., Christensen, H., Cohen Silver, R., Everall, I., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30168-1 · Cited by 5,715
“42 Looking beyond digital interventions (as not everyone has access to them), and ascertaining what other mechanistically based psychological interventions are effective and for whom is important.”
BackgroundSelf-citationStein, D. J., Shoptaw, S. J., Vigo, D. V., Lund, C., Cuijpers, P., Bantjes, J., Sartorius, N., & Maj, M. (2022) · World Psychiatry · doi:10.1002/wps.20998 · Cited by 331
Predicting Symptoms of Depression and Anxiety Using Smartphone and Wearable Data
Moshe, I., Terhorst, Y., Opoku Asare, K., Sander, L. B., Ferreira, D., Baumeister, H., Mohr, D. C., & Pulkki-Råback, L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.625247 · Cited by 261
Singapore's health-care system: key features, challenges, and shifts
Tan, C. C., Lam, C. S. P., Matchar, D. B., Zee, Y. K., & Wong, J. E. L. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00252-x · Cited by 257
Digital mental health: challenges and next steps
Smith, K. A., Blease, C., Faurholt-Jepsen, M., Firth, J., Van Daele, T., Moreno, C., Carlbring, P., Ebner-Priemer, U. W., Koutsouleris, N., Riper, H., et al. (2023) · BMJ Mental Health · doi:10.1136/bmjment-2023-300670 · Cited by 233
Metadata
- Authors
- Huckvale, K., Venkatesh, S., & Christensen, H.
- Affiliations
- Black Dog Institute (AU)
- Deakin University (AU)
- Corresponding author
- Huckvale, Kit
- Venue
- npj Digital Medicine
- Published
- 2019-09-06
- Volume
- 2
- Issue
- 1
- Pages
- 88-88
- ISSN
- 2398-6352 (ISSN-L)
- PMC
- PMC6731256
- OpenAlex
- W2972211076
- Cited by
- 433
- References
- 112
- Citations by year
- 2026: 64 · 2025: 72 · 2024: 63 · 2023: 96 · 2022: 57 · 2021: 42 · 2020: 32 · 2019: 7
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- npj Digital Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- digital phenotyping, clinical adoption, smartphone data, mental health monitoring, relapse detection, digital interventions, consumer acceptance, intermediate outcomes, disease mechanisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety. https://app.cochat.ai/papers/10.1038/s41746-019-0166-1
- The paper
- Huckvale, K., Venkatesh, S., & Christensen, H. (2019). Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety. npj Digital Medicine. https://doi.org/10.1038/s41746-019-0166-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.